Related Experiment Video
Updated: Aug 13, 2026

Reliable and High Efficiency Extraction of Kidney Immune Cells
Published on: August 19, 2016
Microinflammation in hemodialysis is related to a preactivated subset of monocytes
Rafael Ramirez1, Julia Carracedo, Isabel Berdud
1Unidad de Investigación, Servicio de Nefrología, Hospital Universitario Reina Sofía, Córdoba, Spain. manuelr.ramirez.sspa@juntadeadalucia.es
Abstract:
Increased percentage of monocytes with low CD14 expression and that co-express CD16 (CD14+/CD16+) have been reported in hemodialysis (HD) patients. We sought to determine whether CD14+/CD16+ monocytes in HD therapy are sensibilized cells to a proinflammatory activity. Cells from 32 HD patients, and from 9 Systemic Lupus Erythematosus (SLE), 9 individuals with human immunodeficiency virus (HIV)-1- and 15 healthy controls were studied. Cells were analyzed by means of flow cytometry for CD14/CD16 expression and immune function (cytokine, chemokines, and sialoadhesin expression), and phagocytosis. Increased percentage of CD14+/CD16+ monocytes was observed in HD patients. Compared with CD14++ monocytes, the CD14+/CD16+ monocytes exhibited increased expression of proinflammatory cytokines and markers of differentiated cells. In addition, these monocytes showed an increased phagocytic activity. Similarly, CD14+/CD16+ monocytes from SLE and HIV patients showed increased inflammatory activity as compared with CD14++ cells. These results support that CD14+/CD16+ monocytes from HD patients evidence characteristics of primed prestimulated proinflammatory cells, similar to data observed in SLE and HIV.
Insights
In hemodialysis patients, a specific monocyte subset (CD14+/CD16+) shows heightened inflammatory activity and phagocytosis. These primed cells exhibit proinflammatory characteristics, similar to those seen in Systemic Lupus Erythematosus and HIV.
Area of Science:
- Immunology
- Cell Biology
- Nephrology
Background:
- Monocytes with low CD14 and co-expressing CD16 (CD14+/CD16+) are increased in hemodialysis (HD) patients.
- The functional significance of this monocyte subset in HD patients remains unclear.
Purpose of the Study:
- To investigate if CD14+/CD16+ monocytes in HD patients are primed for proinflammatory activity.
- To compare the immune function of CD14+/CD16+ monocytes with CD14++ monocytes in HD patients and other conditions.
Main Methods:
- Flow cytometry was used to analyze CD14/CD16 expression on monocytes.
- Immune function was assessed by measuring cytokine, chemokine, and sialoadhesin expression, as well as phagocytosis.
- Cells from 32 HD patients, 9 Systemic Lupus Erythematosus (SLE) patients, 9 HIV-1 patients, and 15 healthy controls were analyzed.
Main Results:
- HD patients exhibited an increased percentage of CD14+/CD16+ monocytes.
- Compared to CD14++ monocytes, CD14+/CD16+ monocytes showed increased expression of proinflammatory cytokines and differentiated cell markers.
- CD14+/CD16+ monocytes from HD patients demonstrated enhanced phagocytic activity, mirroring findings in SLE and HIV patients.
Conclusions:
- CD14+/CD16+ monocytes in HD patients display characteristics of primed, prestimulated proinflammatory cells.
- These findings suggest a potential role for this monocyte subset in the inflammatory state associated with hemodialysis.
- The observed inflammatory profile of CD14+/CD16+ monocytes in HD is comparable to that in SLE and HIV patients.
Related Concept Videos
Chronic Inflammation: Introduction
Diabetic Nephropathy